Ventripoint Diagnostics Ltd. (TSXV: VPT)

Market Cap	22.67M
Revenue (ttm)	72.07K
Net Income (ttm)	-5.02M
Shares Out	161.91M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	99,030
Open	0.145
Previous Close	0.140
Day's Range	0.140 - 0.145
52-Week Range	0.140 - 0.360
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Ventripoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, in...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Hugh MacNaught
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: VPT

Financial Performance

In 2023, Ventripoint Diagnostics's revenue was 49,183, a decrease of -27.85% compared to the previous year's 68,167. Losses were -4.87 million, -0.02% less than in 2022.